December 10, 2020

Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community.

Read the Letter

Tags: Cardiovascular, Cost Value

Categorized in: Analysis

Recent Blog Posts

Hidden Co-Pay Programs Blindside Patients September 16, 2021

The Urgent Need to Address Urology Health September 14, 2021

New Federal Policy Could Limit Non-Opioid Pain Treatments September 10, 2021